Short Interest in Idorsia Ltd (OTCMKTS:IDRSF) Declines By 12.6%

Idorsia Ltd (OTCMKTS:IDRSFGet Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 6,314,900 shares, a decrease of 12.6% from the December 15th total of 7,229,000 shares. Based on an average trading volume of 12,600 shares, the short-interest ratio is presently 501.2 days.

Idorsia Price Performance

Idorsia stock opened at $0.91 on Friday. Idorsia has a 12 month low of $0.70 and a 12 month high of $2.88. The company has a fifty day moving average price of $0.98 and a two-hundred day moving average price of $1.84.

Idorsia Company Profile

(Get Free Report)

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.

Featured Stories

Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.